SIRT2 and glioblastoma: In particular, Funato and colleagues showed that the SIRT-2-mediated inactivation of tumor suppressor p73 is crucial in the proliferation and tumorigenicity of glioblastoma cells, thus making SIRT-2 inhibition by AGK2 or AK7 a valid anti-cancer treatment [88].